Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000914062-13-000232)

Filing Details

Accession Number:: 0000914062-13-000232
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-10-03 17:18:05
Reporting Period:: 2013-10-01

Filing Date:: 2013-10-03
Accepted Time:: 2013-10-03 17:18:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133416	Galectin Therapeutics Inc	GALT	Pharmaceutical Preparations (2834)	043562325

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1522480	F John Mauldin	C/O Galectin Therapeutics Inc. 4960 Peachtree Industrial Blvd, Ste 240 Norcross GA 30071		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-10-01	376	$9.96	16,244	No	4	P	Direct
Common Stock	Acquisiton	2013-10-02	125	$9.97	16,369	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,947	Indirect	By Trust

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2013.
Reflects weighted average price. Range of prices were between $9.95 and $9.97. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.